Thalamotomy for Parkinson's Disease Tremors

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease

Recruiting Observational Study
Tremor Associated With Tremor Dominant Parkinson's Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 99
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
InSightec · Industry
Who this trial is looking for

This trial is looking for adults with tremors from Parkinson's disease. Participants will undergo a specific procedure to see how safe and effective it is over time.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 30 years or older
  • I have Parkinson's disease and am planning to receive the Exablate procedure
  • I am willing to follow the study requirements and attend all visits
  • I have signed the informed consent form

You may not be able to join if

  • I do not want to participate or likely cannot participate for the entire study

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Men and women, age 30 years and older 2. Subject undergoing an Exablate procedure for their planned TDPD treatment; per local institution standard of care. 3. Subject is willing to cooperate with the Registry requirements including compliance with the regimen and completion o…
Contacts

Matt Hibert

214-630-2000

clinicalresearchquestions@insightec.com

CONTACT